Kent Douglas Cunningham - 24 Jun 2024 Form 4 Insider Report for SRx Health Solutions, Inc. (SRXH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Apr 2026, 11:04:57 UTC
Prior SEC filing
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Carolina Martinez, Attorney-in- fact

Key filing fact

Kent Douglas Cunningham filed Form 4 for SRx Health Solutions, Inc. (SRXH) on 03 Apr 2026.

Key facts

  • This page summarizes Kent Douglas Cunningham's Form 4 filing for SRx Health Solutions, Inc. (SRXH).
  • 9 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2026, 11:04.

Change

  • Previous filing in this sequence was filed on 03 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002097408 Primary reporting owner

Cunningham Kent Douglas

Relationship
Chief Executive Officer
Address
801 US HIGHWAY 1, NORTH PALM BEACH
Signature
/s/ Carolina Martinez, Attorney-in- fact
Signature date
03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRXH transaction

Common Stock

Award

Transaction value
Shares
+200,000
Change %
+44%
Price
$0.3900*
Shares after
655,060
Date
03 Dec 2025
Ownership
Direct
SRXH transaction

Common Stock

Award

Transaction value
Shares
+44,464
Change %
+11%
Price
$0.3300*
Shares after
455,060
Date
26 Sep 2025
Ownership
Indirectly owned through ownership in Halo Spin-Out SPV Inc.
SRXH transaction

Common Stock

Award

Transaction value
Shares
+231,193
Change %
+129%
Price
$0.4040*
Shares after
410,596
Date
25 Aug 2025
Ownership
Direct
SRXH transaction

Common Stock

Award

Transaction value
Shares
+84,906
Change %
+90%
Price
$1.59*
Shares after
179,403
Date
25 Apr 2025
Ownership
Direct
SRXH transaction

Common Stock

Award

Transaction value
Shares
+71,770
Change %
+316%
Price
$2.09*
Shares after
94,497
Date
24 Apr 2025
Ownership
Direct
SRXH transaction

Common Stock

Award

Transaction value
Shares
+22,727
Change %
Price
$4.17*
Shares after
22,727
Date
26 Jun 2024
Ownership
Direct
SRXH transaction

Series B Preferred Stock

Award

Transaction value
Shares
+63
Change %
Price
$800.00*
Shares after
63
Date
16 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRXH transaction Derivative

Stock Options - Right to Buy

Award

Transaction value
Shares
+8,000
Change %
Price
$5.00*
Shares after
8,000
Date
26 Jun 2024
Ownership
Direct
Underlying class
Common stock
Underlying amount
8,000
Exercise price
$5.00
SRXH transaction Derivative

Series B Warrants

Award

Transaction value
Shares
+247,522
Change %
Price
$0.3182*
Shares after
247,522
Date
16 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
247,522
Exercise price
$0.3182
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .